Deep Adaptive Model-Based Design of Experiments

arXiv stat.ML / 3/25/2026

💬 OpinionSignals & Early TrendsIdeas & Deep AnalysisModels & Research

Key Points

  • The paper proposes a deep adaptive model-based design of experiments (MBDOE) method to speed up parameter estimation in nonlinear dynamical systems where conventional adaptive approaches are too slow for real-time use.
  • It combines Deep Adaptive Design (DAD), which amortizes sequential experimental design into an offline-trained neural network policy, with differentiable mechanistic models to enable fast deployment.
  • The authors extend sequential contrastive training objectives to account for nuisance parameters (in addition to uncertain parameters) and maintain the temporal structure of dynamical systems using a transformer-based policy.
  • Experiments on four progressively complex dynamical systems—including bioreactors, a pharmacokinetic model, and a DC motor—illustrate the method’s suitability for real-time deployment.
  • Overall, the work targets reducing the need for costly posterior inference and per-step design optimization between experiments by learning a reusable policy from offline training.

Abstract

Model-based design of experiments (MBDOE) is essential for efficient parameter estimation in nonlinear dynamical systems. However, conventional adaptive MBDOE requires costly posterior inference and design optimization between each experimental step, precluding real-time applications. We address this by combining Deep Adaptive Design (DAD), which amortizes sequential design into a neural network policy trained offline, with differentiable mechanistic models. For dynamical systems with known governing equations but uncertain parameters, we extend sequential contrastive training objectives to handle nuisance parameters and propose a transformer-based policy architecture that respects the temporal structure of dynamical systems. We demonstrate the approach on four systems of increasing complexity: a fed-batch bioreactor with Monod kinetics, a Haldane bioreactor with uncertain substrate inhibition, a two-compartment pharmacokinetic model with nuisance clearance parameters, and a DC motor for real-time deployment.